Business Information
The group's principal activities are to develop, manufacture and commercialize critical care blood and tissue analysis systems. This provides immediate or continuous diagnostic result at the point-of-patient care. The group has two primary product platforms namely intermittent blood testing products and monitoring products. Intermittent blood testing products based primarily on electrochemical technology, which performs the tests for critical care patients. Continuous monitoring products based upon fiber optic technology, which provides direct continuous monitoring of blood gases and temperature for pediatric patients. The system also includes neurotrend cerebral tissue monitoring system which measures oxygen, carbon dioxide, acidity and temperature in brain tissue and fluids. The group's principal products are irma sl series 2000 blood analysis system, irma sl analyzer idms, capillary collection device and trendcare continuous blood gas monitoring system.
|
|
Name |
Title
|
Email
|
| Darrell Dubroc | Dir., COO, Pres. | N/A | | Heng Chuk | Dir., CFO, Sec. | N/A | | Tim Collins | Dir., Exec. VP - Business Development | N/A | | Bruce Comer | Dir., CEO | N/A | | Jeffrey Lawton | Dir. | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 1,803 | (75,250) | | 2005 | N/A | (10,032) | | 2004 | N/A | (10,979)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
